Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vivo and in vitro availability of commercial warfarin tablets.

× No keyword cloud information.

10 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

2. Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9.

Authors: Kerenaftali Klein; Ivelina Gueorguieva; Leon Aarons
Journal: J Pharmacokinet Pharmacodyn Date: 2012-01-21 Impact factor: 2.745

Review 3. Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges.

Authors: Hong Wen; Huijeong Jung; Xuhong Li
Journal: AAPS J Date: 2015-08-15 Impact factor: 4.009

4. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.

Authors: V F Smolen
Journal: J Pharmacokinet Biopharm Date: 1976-08

5. Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1973-04

6. Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics.

Authors: S Y Lin; J C Yang
Journal: Pharm Weekbl Sci Date: 1986-08-22

7. Comparative bioavailability of three brands of ampicillin.

Authors: C MacLeod; H Rabin; J Ruedy; M Caron; D Zarowny; R O Davies
Journal: Can Med Assoc J Date: 1972-08-05 Impact factor: 8.262

8. Population pharmacokinetics of racemic warfarin in adult patients.

Authors: D R Mungall; T M Ludden; J Marshall; D W Hawkins; R L Talbert; M H Crawford
Journal: J Pharmacokinet Biopharm Date: 1985-06

9. Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation.

Authors: Inna Y Gong; Ute I Schwarz; Natalie Crown; George K Dresser; Alejandro Lazo-Langner; GuangYong Zou; Dan M Roden; C Michael Stein; Marc Rodger; Philip S Wells; Richard B Kim; Rommel G Tirona
Journal: PLoS One Date: 2011-11-16 Impact factor: 3.240

10. Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence.

Authors: X Zhang; H Wen; J Fan; B Vince; T Li; W Gao; M Kinjo; J Brown; W Sun; W Jiang; R Lionberger
Journal: CPT Pharmacometrics Syst Pharmacol Date: 2017-07-13

10 in total